We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1508:HKEXChina Reinsurance (Group) Corporation Analysis

Data as of 2026-03-16 - not real-time

HK$1.69

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

China Reinsurance (Group) Corporation trades at a markedly low price‑to‑earnings multiple compared with its industry peers, delivering a compelling value proposition supported by a robust dividend yield and a payout ratio well below its earnings capacity. The stock’s price sits comfortably above its long‑term moving average, with the 20‑day and 50‑day averages converging near the current level, indicating a stable support framework. Technical momentum is bullish, as reflected by a positive MACD histogram and a neutral‑to‑slightly‑positive RSI, while volume trends are on the rise, suggesting accumulating interest. Fundamentally, the low price‑to‑book ratio and a discounted discounted cash‑flow estimate point to upside potential, albeit modest, in the near term.
Risk considerations include elevated short‑term volatility and a modest beta, implying limited correlation with broader market swings but heightened idiosyncratic exposure. The reinsurance sector carries moderate regulatory and geographic risks given its concentration in China and the evolving policy landscape. Nonetheless, the company’s strong cash generation, manageable debt levels, and ample liquidity mitigate downside concerns, making a cautiously optimistic stance appropriate across investment horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to industry multiples
  • Bullish MACD and rising volume
  • Attractive dividend yield with low payout ratio

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained cash flow generation despite negative free cash flow
  • Potential earnings recovery as reinsurance premiums stabilize
  • Continued dividend support enhancing total return

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term demand for reinsurance services in China and abroad
  • Exposure to regulatory shifts and macro‑economic cycles
  • Valuation remains attractive but upside may be limited

Key Metrics & Analysis

Financial Health

Revenue Growth-0.80%
Profit Margin10.73%
P/E Ratio5.5
ROE10.48%
ROA1.79%
Debt/Equity61.69
P/B Ratio0.6
Op. Cash FlowHK$15.4B
Free Cash FlowHK$-7912647168
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI51.0
SupportHK$1.55
ResistanceHK$1.84
MA 20HK$1.66
MA 50HK$1.69
MA 200HK$1.53
MACDBullish
VolumeIncreasing
Fear & Greed Index78.86

Valuation

Fair ValueHK$4.99
Target PriceHK$1.76
Upside/Downside3.95%
GradeUndervalued
TypeValue
Dividend Yield3.26%

Risk Assessment

Beta0.05
Volatility46.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.